GEORGANNE VOGT: Open Payments
NPI 1245858562 · ROSWELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$382 in 20 payments from 10 companies in 2025. Trend: 2023 $739 · 2024 $595 · 2025 $382
Food & beverage: $382
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $112 |
| ABBVIE INC. | 2 | $49 |
| Amgen Inc. | 3 | $47 |
| Novo Nordisk Inc | 3 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| PFIZER INC. | 1 | $21 |
| SANOFI-AVENTIS U.S. LLC | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: AIRSUPRA, VRAYLAR, JARDIANCE, TRELEGY ELLIPTA, NURTEC ODT, TZIELD, REPATHA, Wegovy.
Industry payments across GA — which companies pay providers there.
